跳至主要内容
临床试验/CTRI/2025/07/091275
CTRI/2025/07/091275尚未招募2/3 期

A Comparative Pharmaco-Clinical Study of Palash (Butea monosperma Lam.kuntze) and Chakramarda (Cassia tora Linn) in the managenant of Dadru kustha

Pt.khushi lal sharma government Autonomus Ayurveda collage and institute science bhopal mp1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年9月2日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
the reduction or elimination of symptoms like itching (Kandu), redness (Raga), eruptions (Pidika), and elevated circular skin lesions (Utsanna Mandala). Successful treatment aims to alleviate these symptoms and prevent recurrence.

研究概览

简要总结

Aim of the study is to provide a simple, safe and herbal drug for patient of Dadru kustha and Evaluation of efficacy palash beej churna and chakramard beej churna

Participants fulfilling the inclusion criteria will be selected.  Those patients will be selected, who fulfils the criteria of selection and attended the OPD of department of kayachikitsa at Pt. Khushilal Sharma Govt. (Auto.) Ayurveda College and Institute Bhopal.  The clinical trial will be taken out on 40 (20 Participants in each group) and they were randomly selected and divided into 2 groups:

Group A- Study group

Group B- Study group

Including symptoms: kandu ,raga,pidika,daha,Rooksha,Uttana mandala

Assessment criteria: Subjective parameters will be scored as mentioned in specially designed scale and will be compared before and after treatment.

Objective parameter will also be compared at the same interval.

The assessment criteria for Dadru kustha will be mainly based on:

[a] Subjective criteria: 1.Kandu (itching) 2.Raga (Erythema) 3.Pidaka 4.Daha 5.Rooksha 6.Unnata mandala (Raised border ring)

[b]. Objective criteria:

Investigation: Blood: CBC,RBS

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
21.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Individuals aged between 21-50 years without any discrimination of gender, caste, and religion, Patients fulfilling the diagnostic criteria.
  • Individuals having clinical sign and symptoms of Dadru roga according to Ayurvedic classics.
  • Individuals who will give written consent for the study.

排除标准

  • Pregnancy and Lactating mothers.
  • Subject having skin disorder other than Dadru.
  • Immunocompromised patient (HIV, T.B.,) other complicated disorder uncontrolled diabetes, skin cancer, psoriasis, malignant of skin diseases, Generalized eczema, hansen’s disease, cellulitis and other autoimmune disease Patient who used to Immunosuppressive drugs.

结局指标

主要结局

the reduction or elimination of symptoms like itching (Kandu), redness (Raga), eruptions (Pidika), and elevated circular skin lesions (Utsanna Mandala). Successful treatment aims to alleviate these symptoms and prevent recurrence.

时间窗: 7 week

次要结局

  • Complete Blood Count (CBC)(RBS)

研究者

发起方
Pt.khushi lal sharma government Autonomus Ayurveda collage and institute science bhopal mp
申办方类型
Other [state Government Ayurveda collage and institute]
责任方
Principal Investigator
主要研究者

Dr Ajay kurmi

Pt.khushi lal sharma government Autonomus Ayurveda collage and institute science bhopal

研究点 (1)

Loading locations...

相似试验